Sonnet Biotherapeutics Holdings Inc (SONN) — Capital Reinvestment Ratio

Latest as of September 2018: 1.54x

Sonnet Biotherapeutics Holdings Inc (SONN) has a Capital Reinvestment Ratio of 1.54x as of September 2018, meaning it reinvests 2% of its operating cash flow ($670.16K) in capital expenditures ($1.03 Million). See Sonnet Biotherapeutics Holdings Inc balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.54x

Capex / Operating Cash Flow

Operating Cash Flow

$670.16K

USD

Capital Expenditures

$1.03 Million

USD

Data as of

Sep 2018

Most recent filing

Annual Capital Reinvestment Ratio for Sonnet Biotherapeutics Holdings Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Sonnet Biotherapeutics Holdings Inc from None to None. For live market cap and broader valuation context, see Sonnet Biotherapeutics Holdings Inc market cap and net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow